136 related articles for article (PubMed ID: 9362452)
21. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes.
Thornburg NJ; Raab-Traub N
J Virol; 2007 Dec; 81(23):12954-61. PubMed ID: 17881446
[TBL] [Abstract][Full Text] [Related]
22. Multiple carboxyl-terminal regions of the EBV oncoprotein, latent membrane protein 1, cooperatively regulate signaling to B lymphocytes via TNF receptor-associated factor (TRAF)-dependent and TRAF-independent mechanisms.
Busch LK; Bishop GA
J Immunol; 2001 Nov; 167(10):5805-13. PubMed ID: 11698454
[TBL] [Abstract][Full Text] [Related]
23. The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells.
Miller WE; Cheshire JL; Baldwin AS; Raab-Traub N
Oncogene; 1998 Apr; 16(14):1869-77. PubMed ID: 9583684
[TBL] [Abstract][Full Text] [Related]
24. Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells.
Yang J; Deng X; Deng L; Gu H; Fan W; Cao Y
J Exp Clin Cancer Res; 2004 Sep; 23(3):495-506. PubMed ID: 15595642
[TBL] [Abstract][Full Text] [Related]
25. LMP1 TRAFficking activates growth and survival pathways.
Soni V; Cahir-McFarland E; Kieff E
Adv Exp Med Biol; 2007; 597():173-87. PubMed ID: 17633026
[TBL] [Abstract][Full Text] [Related]
26. The C-terminal activating region 2 of the Epstein-Barr virus-encoded latent membrane protein 1 activates NF-kappaB through TRAF6 and TAK1.
Wu L; Nakano H; Wu Z
J Biol Chem; 2006 Jan; 281(4):2162-9. PubMed ID: 16280329
[TBL] [Abstract][Full Text] [Related]
27. Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3.
Edwards RH; Marquitz AR; Raab-Traub N
mBio; 2015 Apr; 6(2):. PubMed ID: 25873381
[TBL] [Abstract][Full Text] [Related]
28. Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus.
Dirmeier U; Neuhierl B; Kilger E; Reisbach G; Sandberg ML; Hammerschmidt W
Cancer Res; 2003 Jun; 63(11):2982-9. PubMed ID: 12782607
[TBL] [Abstract][Full Text] [Related]
29. LMP1 structure and signal transduction.
Eliopoulos AG; Young LS
Semin Cancer Biol; 2001 Dec; 11(6):435-44. PubMed ID: 11669605
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3.
Kung CP; Raab-Traub N
J Virol; 2008 Jun; 82(11):5486-93. PubMed ID: 18367518
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus latent membrane protein 1 modulates distinctive NF- kappaB pathways through C-terminus-activating region 1 to regulate epidermal growth factor receptor expression.
Kung CP; Raab-Traub N
J Virol; 2010 Jul; 84(13):6605-14. PubMed ID: 20410275
[TBL] [Abstract][Full Text] [Related]
32. [Construction and function analysis of a CTAR-2 region mutant of the Epstein-Barr virus-encoded latent membrane protein-1].
He ZM; Chen ZC
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Mar; 35(3):261-5. PubMed ID: 12621551
[TBL] [Abstract][Full Text] [Related]
33. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production.
Eliopoulos AG; Gallagher NJ; Blake SM; Dawson CW; Young LS
J Biol Chem; 1999 Jun; 274(23):16085-96. PubMed ID: 10347160
[TBL] [Abstract][Full Text] [Related]
34. The transmembrane domains of the EBV-encoded latent membrane protein 1 (LMP1) variant CAO regulate enhanced signalling activity.
Blake SM; Eliopoulos AG; Dawson CW; Young LS
Virology; 2001 Apr; 282(2):278-87. PubMed ID: 11289810
[TBL] [Abstract][Full Text] [Related]
35. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.
Devergne O; Hatzivassiliou E; Izumi KM; Kaye KM; Kleijnen MF; Kieff E; Mosialos G
Mol Cell Biol; 1996 Dec; 16(12):7098-108. PubMed ID: 8943365
[TBL] [Abstract][Full Text] [Related]
36. Negative regulation of Epstein-Barr virus latent membrane protein 1-mediated functions by the bone morphogenetic protein receptor IA-binding protein, BRAM1.
Chung PJ; Chang YS; Liang CL; Meng CL
J Biol Chem; 2002 Oct; 277(42):39850-7. PubMed ID: 12181323
[TBL] [Abstract][Full Text] [Related]
37. Two carboxyl-terminal activation regions of Epstein-Barr virus latent membrane protein 1 activate NF-kappaB through distinct signaling pathways in fibroblast cell lines.
Saito N; Courtois G; Chiba A; Yamamoto N; Nitta T; Hironaka N; Rowe M; Yamamoto N; Yamaoka S
J Biol Chem; 2003 Nov; 278(47):46565-75. PubMed ID: 12968033
[TBL] [Abstract][Full Text] [Related]
38. Roles of TNF receptor-associated factor 3 in signaling to B lymphocytes by carboxyl-terminal activating regions 1 and 2 of the EBV-encoded oncoprotein latent membrane protein 1.
Xie P; Bishop GA
J Immunol; 2004 Nov; 173(9):5546-55. PubMed ID: 15494504
[TBL] [Abstract][Full Text] [Related]
39. Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.
Gires O; Zimber-Strobl U; Gonnella R; Ueffing M; Marschall G; Zeidler R; Pich D; Hammerschmidt W
EMBO J; 1997 Oct; 16(20):6131-40. PubMed ID: 9359753
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation.
Miller WE; Mosialos G; Kieff E; Raab-Traub N
J Virol; 1997 Jan; 71(1):586-94. PubMed ID: 8985387
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
